Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacology
Reference132 articles.
1. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;New Engl J Med,2013
2. Gemcitabine versus modified gemcitabine: a review of several promising chemical modifications;Moysan;Mol Pharm,2013
3. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine;Abbruzzese;J Clin Oncol,1991
4. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity;Celia;Expert Opin Drug Deliv,2011
5. Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine;Dubey;Eur J Pharm Sci,2016
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer;Journal of Controlled Release;2024-01
2. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation;Molecular Cancer;2023-10-09
3. Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies;Cancer Letters;2023-10
4. Preclinical safety study of a gemcitabine-controlled release polymer for locoregional administration in pancreatic cancer;Journal of Drug Delivery Science and Technology;2023-09
5. Harnessing chitosan-adorned liposomes for enhanced drug delivery in cancer;Journal of Drug Delivery Science and Technology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3